Also trades as: ABBV (NYSE) · $vol 1483M · 0QCV.L (LSE) · $vol 3M · 4AB.DE (XETRA) · $vol 0M · ABBV.BA (BUE) · $vol 0M
4AB.DU DUS
AbbVie Inc.
1W: +3.1%
1M: +3.6%
3M: -5.2%
YTD: -2.1%
1Y: +16.2%
3Y: +38.1%
5Y: +141.8%
€182.45 ($212.13)
-1.60 (-0.87%)
Weekly Expected Move ±4.2%
€167
€175
€182
€190
€198
Overview
News
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
Supply Chain
Smart Money Score
No convergence signal
Key Statistics
Market Cap€322.6B ($375.1B)
52W Range155.6-206
Volume0
Avg Volume1
Beta0.03
Dividend€5.76
Analyst Ratings
Company Info
CEORichard A. Gonzalez
Employees50,000
SectorHealthcare
IndustryDrug Manufacturers - General
IPO Date2020-02-20
Websiteabbvie.com
1 N. Waukegan Road
North Chicago, IL 60064
US
North Chicago, IL 60064
US
+1 847 932 7900
About AbbVie Inc.
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.
Latest News
No recent news
Recent Insider Trades
No insider trades found